Lee Ainslie's TECH Position Overview
Lee Ainslie (via Maverick Capital LTD) currently holds 3.01 M shares of Bio-Techne Corporation (TECH) worth $167.59 M, representing 2.24% of the portfolio. First purchased in 2019-Q4, this medium-term investment has been held for 10 quarters.
Based on 13F filings, Lee Ainslie has maintained a strategic position in TECH, demonstrating sustained confidence in this investment. Largest addition occurred in Q3 2025, adding 3.01 M shares. Largest reduction occurred in Q2 2025, reducing 522,897 shares.
Analysis based on 13F filings available since 2013 Q2
Lee Ainslie's Bio-Techne Corporation (TECH) Holding Value Over Time
Track share changes against reported price movement
Quarterly Bio-Techne Corporation (TECH) Trades by Lee Ainslie
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q4 2019 | +36,916 | New Buy | 36,916 | $54.88 |
| Q1 2020 | -3,284 | Reduce 8.90% | 33,632 | $47.40 |
| Q2 2020 | -32,076 | Reduce 95.37% | 1,556 | $66.20 |
| Q3 2020 | +1,272 | Add 81.75% | 2,828 | $61.88 |
| Q4 2020 | +5,916 | Add 209.19% | 8,744 | $79.37 |
| Q1 2021 | -2,640 | Reduce 30.19% | 6,104 | $95.51 |
| Q2 2021 | -6,104 | Sold Out | 0 | $0.00 |
| Q1 2025 | +522,897 | New Buy | 522,897 | $58.63 |
| Q2 2025 | -522,897 | Sold Out | 0 | $0.00 |
| Q3 2025 | +3.01 M | New Buy | 3.01 M | $55.63 |
Lee Ainslie's Bio-Techne Corporation Investment FAQs
Lee Ainslie first purchased Bio-Techne Corporation (TECH) in Q4 2019, acquiring 36,916 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Lee Ainslie has held Bio-Techne Corporation (TECH) for 10 quarters since Q4 2019.
Lee Ainslie's largest addition to Bio-Techne Corporation (TECH) was in Q3 2025, adding 3,012,654 shares worth $167.59 M.
According to the latest 13F filing for Q3 2025, Lee Ainslie's firm, Maverick Capital LTD, owns 3,012,654 shares of Bio-Techne Corporation (TECH), valued at approximately $167.59 M.
As of the Q3 2025 filing, Bio-Techne Corporation (TECH) represents approximately 2.24% of Lee Ainslie's publicly disclosed stock portfolio, making it one of their key holdings.
Lee Ainslie's peak holding in Bio-Techne Corporation (TECH) was 3,012,654 shares, as reported at the end of Q3 2025.